Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gueyffier

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Diabetes & Metabolism|February 8, 2014
Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: what is the level of evidence?R Boussageon, F Gueyffier, C Cornu
Therapie|May 1, 1996
[Integratable message: central problem of communication for therapeutic information]F Gueyffier, J P Boissel, M Cucherat
American Journal of Hypertension|July 31, 1998
What target for guidelines: uniformed or tailored?J P Boissel, M Cucherat, F Gueyffier
Therapie|January 1, 1997
[Role of meta-analysis in the definition of target population in therapy]J P Boissel, M Cucherat, F Gueyffier
Archives Des Maladies Du Coeur Et Des Vaisseaux|August 1, 1997
[The Hypertension Cochrane Review Group. Presentation and user's guide]F Gueyffier, J P Boissel, M Haugh
Therapie|October 27, 2001
[Biological markers: utilization in drug development and approval]F Gueyffier, M Dib, J P Boissel
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1991
[Value of a new fast CK-MB determination for the diagnosis of myocardial infarction during the 1st hours. Preliminary study]F Gueyffier, M Gallet, P Chapon, et al.
Lancet (London, England)|May 29, 1999
CAPPP trial. Captopril Prevention ProjectF Gueyffier, J P Boissel, P F Plouin
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 8, 2001
[Antihypertensive therapy and improved life expectancy without cerebrovascular accident or coronary artery disease]B Kassaï, F Gueyffier, M Cucherat, et al.
The Cochrane Database of Systematic Reviews|July 25, 2000
Pharmacotherapy for hypertension in women of different racesA Quan, K Kerlikowske, F Gueyffier, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Diabetes & Metabolism|February 8, 2014
Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: what is the level of evidence?R Boussageon, F Gueyffier, C Cornu
Therapie|May 1, 1996
[Integratable message: central problem of communication for therapeutic information]F Gueyffier, J P Boissel, M Cucherat
American Journal of Hypertension|July 31, 1998
What target for guidelines: uniformed or tailored?J P Boissel, M Cucherat, F Gueyffier
Therapie|January 1, 1997
[Role of meta-analysis in the definition of target population in therapy]J P Boissel, M Cucherat, F Gueyffier
Archives Des Maladies Du Coeur Et Des Vaisseaux|August 1, 1997
[The Hypertension Cochrane Review Group. Presentation and user's guide]F Gueyffier, J P Boissel, M Haugh
Therapie|October 27, 2001
[Biological markers: utilization in drug development and approval]F Gueyffier, M Dib, J P Boissel
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1991
[Value of a new fast CK-MB determination for the diagnosis of myocardial infarction during the 1st hours. Preliminary study]F Gueyffier, M Gallet, P Chapon, et al.
Lancet (London, England)|May 29, 1999
CAPPP trial. Captopril Prevention ProjectF Gueyffier, J P Boissel, P F Plouin
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 8, 2001
[Antihypertensive therapy and improved life expectancy without cerebrovascular accident or coronary artery disease]B Kassaï, F Gueyffier, M Cucherat, et al.
The Cochrane Database of Systematic Reviews|July 25, 2000
Pharmacotherapy for hypertension in women of different racesA Quan, K Kerlikowske, F Gueyffier, et al.
Pageof 7